MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.675
-0.002 (-0.33%)
Oct 10, 2024, 11:50 AM EDT - Market open
MiNK Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 9.31 | 3.37 | 19.64 | 38.89 | 2.69 | 0.3 |
Cash & Short-Term Investments | 9.31 | 3.37 | 19.64 | 38.89 | 2.69 | 0.3 |
Cash Growth | -12.32% | -82.85% | -49.51% | 1345.06% | 799.94% | - |
Other Receivables | - | - | - | - | 0.25 | 0.53 |
Receivables | - | - | - | - | 0.25 | 0.53 |
Prepaid Expenses | 0.1 | 0.05 | 0.3 | 0 | 0.49 | 0.09 |
Other Current Assets | 0.06 | 0.18 | 0.47 | 0.74 | 0.66 | 0.01 |
Total Current Assets | 9.47 | 3.6 | 20.4 | 39.63 | 4.1 | 0.92 |
Property, Plant & Equipment | 0.85 | 0.95 | 1.07 | 0.61 | 0.46 | 0.39 |
Total Assets | 10.32 | 4.55 | 21.47 | 40.24 | 4.56 | 1.31 |
Accounts Payable | 3.2 | 3.91 | 5.82 | 3 | 3.14 | 2.46 |
Accrued Expenses | 4.63 | 5.04 | 4.24 | 1.76 | 1.86 | 2.6 |
Current Unearned Revenue | - | - | - | - | - | 0.19 |
Other Current Liabilities | 2.32 | 2.45 | 2.62 | 11.71 | 9.22 | 2.17 |
Total Current Liabilities | 10.15 | 11.4 | 12.68 | 16.47 | 14.22 | 7.42 |
Long-Term Debt | 4.41 | - | - | - | 43.82 | 26.79 |
Other Long-Term Liabilities | 12.35 | 11.21 | 9.19 | - | 0.38 | 3.43 |
Total Liabilities | 26.9 | 22.61 | 21.87 | 16.47 | 58.43 | 37.64 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 123.95 | 115.77 | 110.83 | 107.35 | 0.38 | 0.29 |
Retained Earnings | -139.91 | -133.4 | -110.94 | -82.95 | -52.74 | -36.5 |
Comprensive Income & Other | -0.61 | -0.43 | -0.29 | -0.63 | -1.52 | -0.13 |
Shareholders' Equity | -16.58 | -18.06 | -0.4 | 23.78 | -53.87 | -36.33 |
Total Liabilities & Equity | 10.32 | 4.55 | 21.47 | 40.24 | 4.56 | 1.31 |
Total Debt | 4.41 | - | - | - | 43.82 | 26.79 |
Net Cash (Debt) | 4.91 | 3.37 | 19.64 | 38.89 | -41.13 | -26.49 |
Net Cash Growth | -53.80% | -82.85% | -49.51% | - | - | - |
Net Cash Per Share | 0.14 | 0.10 | 0.58 | 1.49 | -1.71 | -1.10 |
Filing Date Shares Outstanding | 39.54 | 34.7 | 33.91 | 33.56 | 24.18 | 24.18 |
Total Common Shares Outstanding | 39.45 | 34.6 | 33.86 | 33.48 | 24.18 | 24.06 |
Working Capital | -0.67 | -7.8 | 7.72 | 23.17 | -10.13 | -6.5 |
Book Value Per Share | -0.42 | -0.52 | -0.01 | 0.71 | -2.23 | -1.51 |
Tangible Book Value | -16.58 | -18.06 | -0.4 | 23.78 | -53.87 | -36.33 |
Tangible Book Value Per Share | -0.42 | -0.52 | -0.01 | 0.71 | -2.23 | -1.51 |
Machinery | 1.26 | 1.45 | 1.35 | 0.78 | 0.56 | 0.43 |
Source: S&P Capital IQ. Standard template. Financial Sources.